Menu
01. Mesothelioma Care

Mesothelioma Care at Providence Cancer Institute – Franz Clinic

The Franz Clinic, which is a part of the Providence Cancer Institute and Providence Alaska Medical Center, treats mesothelioma at their center. Through their Thoracic Surgery Clinic, they are able to provide multidisciplinary care and options for patients who have been diagnosed with mesothelioma.

The Thoracic Surgery Clinic specializes in video-assisted thoracic surgery (VATS), which is used to perform minimally invasive procedures. The Clinic also offers innovative treatment options such as immunotherapy and personalized cancer medicine through genomics. In their weekly tumor conferences, they discuss a patient’s condition and establish a personalized treatment plan for each diagnosis.

The Franz Clinic offers clinical trials to patients who may be eligible in order to provide alternative treatment that can potentially extend the quality of life and life expectancy of a patient. Peer and support groups, as well as guest housing, rehabilitation services and child care, are also available at the Clinic for patients to utilize.

02. Specializations

Providence Cancer Institute – Franz Clinic Specializations

  • Biotherapy
  • Chemotherapy
  • CyberKnife
  • Radiation therapy
  • Robotic-assisted surgery
  • VATS (video-assisted thoracic surgery)
03. Accreditations

Providence Cancer Institute – Franz Clinic Accreditations

  • ACR-ASTRO Accreditation For Radiation Oncology
  • American College of Surgeons NSQIP meritorious surgical outcomes
  • Commission on Cancer (CoC) Comprehensive Cancer Center
04. Mesothelioma Clinical Trials

Mesothelioma Clinical Trials at Providence Cancer Institute – Franz Clinic

The following clinical trials are in progress or actively recruiting participants at Providence Cancer Institute – Franz Clinic:

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors


Conditions: Carcinoma, Neoplasms, Carcinoma, Squamous Cell, Adenocarcinoma, Neoplasms, Germ Cell and Embryonal, Mesothelioma, Nasopharyngeal Carcinoma, Cholangiocarcinoma, Carcinoma, Basal Cell, Gastrointestinal Stromal Tumors, Carcinoid Tumor, Carcinoma, Transitional Cell, Carcinoma, Adenoid Cystic, Teratoma, Adenocarcinoma of Lung, Carcinoma, Neuroendocrine, Pheochromocytoma, Seminoma, Choriocarcinoma, Cystadenocarcinoma, Serous, Carcinoma, Endometrioid, Cystadenocarcinoma, Paraganglioma, Chordoma, Hemangiosarcoma, Fibromatosis, Aggressive, Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, Trophoblastic Neoplasms, Gestational Trophoblastic Disease, Nerve Sheath Neoplasms, Neurofibrosarcoma, Thyroid Neoplasms, Fibroma, Cystadenocarcinoma, Mucinous, Pseudomyxoma Peritonei, Vulvar Neoplasms, Sex Cord-Gonadal Stromal Tumors, Adrenocortical Carcinoma, Carcinoma, Islet Cell, Paget Disease, Extramammary, Adenocarcinoma, Papillary, Carcinoma, Acinar Cell, Adenocarcinoma, Bronchiolo-Alveolar, Neoplasms, Unknown Primary, Mixed Tumor, Mullerian, Carcinoma, Giant Cell

Last Updated: May 27, 2021

Status: Recruiting

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors


Conditions: Carcinoma, Melanoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Mesothelioma, Nasopharyngeal Carcinoma, Cholangiocarcinoma, Breast Neoplasms, Lung Neoplasms, Carcinoma, Basal Cell, Squamous Cell Carcinoma of Head and Neck, Endometrial Neoplasms, Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Neuroendocrine, Thymoma, Small Cell Lung Carcinoma, Anus Neoplasms, Vulvar Neoplasms

Last Updated: April 28, 2021

Status: Recruiting

Sorry, there are no clinical trials to display

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors


Conditions: Carcinoma, Neoplasms, Carcinoma, Squamous Cell, Adenocarcinoma, Neoplasms, Germ Cell and Embryonal, Mesothelioma, Nasopharyngeal Carcinoma, Cholangiocarcinoma, Carcinoma, Basal Cell, Gastrointestinal Stromal Tumors, Carcinoid Tumor, Carcinoma, Transitional Cell, Carcinoma, Adenoid Cystic, Teratoma, Adenocarcinoma of Lung, Carcinoma, Neuroendocrine, Pheochromocytoma, Seminoma, Choriocarcinoma, Cystadenocarcinoma, Serous, Carcinoma, Endometrioid, Cystadenocarcinoma, Paraganglioma, Chordoma, Hemangiosarcoma, Fibromatosis, Aggressive, Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, Trophoblastic Neoplasms, Gestational Trophoblastic Disease, Nerve Sheath Neoplasms, Neurofibrosarcoma, Thyroid Neoplasms, Fibroma, Cystadenocarcinoma, Mucinous, Pseudomyxoma Peritonei, Vulvar Neoplasms, Sex Cord-Gonadal Stromal Tumors, Adrenocortical Carcinoma, Carcinoma, Islet Cell, Paget Disease, Extramammary, Adenocarcinoma, Papillary, Carcinoma, Acinar Cell, Adenocarcinoma, Bronchiolo-Alveolar, Neoplasms, Unknown Primary, Mixed Tumor, Mullerian, Carcinoma, Giant Cell

Last Updated: May 27, 2021

Status: Recruiting

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors


Conditions: Carcinoma, Melanoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Mesothelioma, Nasopharyngeal Carcinoma, Cholangiocarcinoma, Breast Neoplasms, Lung Neoplasms, Carcinoma, Basal Cell, Squamous Cell Carcinoma of Head and Neck, Endometrial Neoplasms, Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Neuroendocrine, Thymoma, Small Cell Lung Carcinoma, Anus Neoplasms, Vulvar Neoplasms

Last Updated: April 28, 2021

Status: Recruiting

Photo of Providence Cancer Institute – Franz Clinic

Get Help Contacting Providence Cancer Institute – Franz Clinic

Where Should We Overnight Your Free Guide?



    Privacy policy: All information is secure and will never be released

    TRUSTe